Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Tengs, T. O.
Right arrow Articles by Lin, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tengs, T. O.
Right arrow Articles by Lin, T. H.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Meta-Analysis of Utility Estimates for HIV/AIDS

Tammy O. Tengs, ScD

Health Priorities Research Group, University of California, Irvine

Ting H. Lin, PhD

Health Priorities Research Group, University of California, Irvine

The authors performed a meta-analysis to derive pooled utilities for HIV/AIDS and to assess the relative importance of study design characteristics in predicting utilities. Twenty-five articles were identified reporting 74 unique utilities elicited from 1956 respondents. The authors used a hierarchical linear model to perform the meta-analysis, with disease stage, elicitation method, respondent type, and the upper-bound and lower-bound labels for the utility scale as the independent variables. Disease stage (P = 0.016) and respondent type (P = 0.014) were significant predictors of utility. Elicitation method was of marginal significance (P = 0.052). Bounds were not significant. Pooling utilities, the authors estimate a utility of 0.70 for AIDS, 0.82 for symptomatic HIV, and 0.94 for asymptomatic HIV when the time tradeoff method is used to elicit utilities from patients and the scale ranges from death to perfect health. The pooled utilities reported here should be of great use to researchers performing cost-utility analyses of interventions for HIV/AIDS.

Key Words: AIDS • HIV • utility assessment • meta-analysis • quality of life

Medical Decision Making, Vol. 22, No. 6, 475-481 (2002)
DOI: 10.1177/0272989X02238300
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Arch OphthalmolHome page
M. M. Brown, G. C. Brown, H. C. Brown, J. Peet, and Z. Roth
Value-Based Medicine, Comparative Effectiveness, and Cost-effectiveness Analysis of Topical Cyclosporine for the Treatment of Dry Eye Syndrome
Arch Ophthalmol, February 1, 2009; 127(2): 146 - 152.
[Abstract] [Full Text] [PDF]

Home page
 Int J STD AIDSHome page
S P Tole, G D Sanders, A M Bayoumi, C M Galvin, T N Vinichenko, M L Brandeau, and D K Owens
Cost-effectiveness of voluntary HIV screening in Russia
Int J STD AIDS, January 1, 2009; 20(1): 46 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
D. J. McLernon, J. Dillon, and P. T. Donnan
Systematic Review: Health-State Utilities in Liver Disease: A Systematic Review
Med Decis Making, July 1, 2008; 28(4): 582 - 592.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
G. D. Sanders, A. M. Bayoumi, M. Holodniy, and D. K. Owens
Cost-Effectiveness of HIV Screening in Patients Older than 55 Years of Age
Ann Intern Med, June 17, 2008; 148(12): 889 - 903.
[Abstract] [Full Text] [PDF]

Home page
 Operations ResearchHome page
S. M. Shechter, M. D. Bailey, A. J. Schaefer, and M. S. Roberts
The Optimal Time to Initiate HIV Therapy Under Ordered Health States
Operations Research, January 1, 2008; 56(1): 20 - 33.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
K. E. Bremner, C. A. K. Y. Chong, G. Tomlinson, S. M. H. Alibhai, and M. D. Krahn
A Review and Meta-Analysis of Prostate Cancer Utilities
Med Decis Making, May 1, 2007; 27(3): 288 - 298.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
D. M. Bravata, L. M. Nelson, A. M. Garber, and M. K. Goldstein
Invariance and Inconsistency in Utility Ratings
Med Decis Making, March 1, 2005; 25(2): 158 - 167.
[Abstract] [PDF]

Home page
 NEJMHome page
G. D. Sanders, A. M. Bayoumi, V. Sundaram, S. P. Bilir, C. P. Neukermans, C. E. Rydzak, L. R. Douglass, L. C. Lazzeroni, M. Holodniy, and D. K. Owens
Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy
N. Engl. J. Med., February 10, 2005; 352(6): 570 - 585.
[Abstract] [Full Text] [PDF]

Home page
 Dentomaxillofac RadiolHome page
P. Mileman and W. van den Hout
Preferences for oral health states: effect on prescribing periapical radiographs
Dentomaxillofac. Radiol., November 1, 2003; 32(6): 401 - 407.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
J. M. Mrus, M. S. Yi, K. A. Freedberg, A. W. Wu, R. Zackin, H. Gorski, and J. Tsevat
Utilities Derived from Visual Analog Scale Scores in Patients with HIV/AIDS
Med Decis Making, September 1, 2003; 23(5): 414 - 421.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
W. C. Holmes
HIV/AIDS, Utilities, and Cost-Effectiveness Analysis: Stepping toward the Future
Med Decis Making, December 1, 2002; 22(6): 522 - 525.
[PDF]